Lifeclinic International names new chief medical officer
In this position, Dr Kelly will develop strategies to improve the health and wellness of the users of Lifeclinic’s blood pressure monitors, health stations, and health management systems.
Ionis Pharmaceuticals has entered a licence agreement granting global pharmaceutical company Recordati exclusive rights to develop and commercialise zilganersen to treat Alexander disease (AxD) in countries outside the US.